/ Amitant
/ Amitant


  • Composition :


  • Packaging Sizes/Strengths :

    125/80 mg Capsules (1 Kit of 1 capsule 125 mg + 2 Capsules of 80 mg)

  • Use :

    Chemotherapy induced nausea and vomiting (CINV)

  • Prescription/Non Prescription :


  • Form :


Product Description

Aprepitant is an orally available antiemetic agent that is used to prevent postoperative or cancer chemotherapy related nausea and vomiting. Aprepitant is associated with a low rate of serum enzyme elevations during therapy. Aprepitant is a small molecule, high-affinity substance P antagonist (SPA) with antiemetic activity. Crossing the blood brain barrier, It binds selectively to the human substance P/neurokinin 1 receptor in the central nervous system (CNS), thereby inhibiting receptor binding of endogenous substance P and substance P-induced emesis. This agent has little or no affinity for serotonin type 3 (5-HT3), dopamine, and corticosteroid receptors. Aprepitant is used for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy.

To buy or for more details